Talaris Therapeutics Inc (TALS) has fallen Friday morning, with the stock decreasing -3.33% in pre-market trading to 2.61. TALS's short-term technical score of 42 indicates that the stock has traded less bullishly over the last month than 58% of stocks on the market. In the Biotechnology industry, which ranks 108 out of 146 industries, TALS ranks higher than 53% of stocks. Talaris Therapeutics Inc has fallen 7.22% over the past month, closing at $2.78 on May 26. During this period of time, the stock fell as low as $2.20 and as high as $2.85. TALS has an average analyst recommendation of Sell. The company has an average price target of $2.50.
News Home
Talaris Therapeutics Inc has a Long-Term Technical rank of 75. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 25% of the market scoring higher. In the Biotechnology industry which is number 93 by this metric, TALS ranks better than 93% of stocks.
Premarket Mover: Talaris Therapeutics Inc (TALS) Down 3.33%
Mentioned in this article
TALS has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on TALS!